QDEL.NASDAQQuidelortho CORP

Form 4: Carlyle Group Sells QuidelOrtho Corp Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between July 22 and July 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of shares of common stock.
  • The sales occurred on July 22 and July 23, 2024.
  • The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
  • A total of 234,786 shares were sold across multiple transactions at varying prices.
  • The prices ranged from $34.8854 to $37.07 per share.
  • Following these transactions, Carlyle Group's indirect beneficial ownership stands at 10,327,772 shares.
  • The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
  • The Carlyle Group Inc. and several related entities may be deemed to share beneficial ownership but disclaim it.

Sentiment

Score: 5

Explanation: The document primarily reports factual information about share sales. While a large shareholder selling shares can sometimes be viewed negatively, the existence of a pre-arranged trading plan mitigates some of the potential negative sentiment.

Risks

  • The sale of a significant number of shares by a major shareholder like Carlyle Group could exert downward pressure on QDEL's stock price in the short term.
  • The market may interpret the sale as a lack of confidence in the company's future prospects, regardless of the pre-arranged trading plan.

Future Outlook

The document does not contain any specific forward-looking statements regarding QuidelOrtho's future performance.

Industry Context

Private equity firms like Carlyle Group often have investment horizons that lead to eventual exits. This sale could be part of a broader strategy to realize gains from their investment in QuidelOrtho.

Stakeholder Impact

  • The share sales could potentially impact QuidelOrtho's shareholders through short-term price fluctuations.
  • The impact on employees, customers, suppliers, and creditors is likely to be minimal, as the sales do not directly affect the company's operations.

Key Dates

DateDescription
05/12/2024Date of adoption of the Rule 10b5-1 trading plan
07/22/2024Date of first reported transaction
07/23/2024Date of last reported transaction
07/24/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.